Page last updated: 2024-08-21

quinazolines and Abdominal Neoplasms

quinazolines has been researched along with Abdominal Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Collins, D; deSouza, N; Leach, MO; Messiou, C; Morgan, VA; Orton, MR; Tessier, J; Young, H	1
Collins, DJ; Darcy, J; Desouza, N; Leach, MO; Messiou, C; Orton, MR; Rata, M; Tunariu, N; Young, H	1
Burkitt, V	1

Trials

2 trial(s) available for quinazolines and Abdominal Neoplasms

Article	Year
Diffusion-weighted MR imaging of metastatic abdominal and pelvic tumours is sensitive to early changes induced by a VEGF inhibitor using alternative diffusion attenuation models. European radiology, 2016, Volume: 26, Issue:5 Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Humans; Magnetic Resonance Imaging; Middle Aged; Models, Theoretical; Pelvic Neoplasms; Quinazolines; Vascular Endothelial Growth Factor A; Young Adult	2016
Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions. European radiology, 2016, Volume: 26, Issue:7 Topics: Abdominal Neoplasms; Adult; Aged; Algorithms; Antineoplastic Agents; Aorta; Computer Simulation; Contrast Media; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Quinazolines; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2016

Article

Year

Diffusion-weighted MR imaging of metastatic abdominal and pelvic tumours is sensitive to early changes induced by a VEGF inhibitor using alternative diffusion attenuation models.

European radiology, 2016, Volume: 26, Issue:5

Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Humans; Magnetic Resonance Imaging; Middle Aged; Models, Theoretical; Pelvic Neoplasms; Quinazolines; Vascular Endothelial Growth Factor A; Young Adult

2016

Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.

European radiology, 2016, Volume: 26, Issue:7

Topics: Abdominal Neoplasms; Adult; Aged; Algorithms; Antineoplastic Agents; Aorta; Computer Simulation; Contrast Media; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Quinazolines; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed

2016

Other Studies

1 other study(ies) available for quinazolines and Abdominal Neoplasms

Article	Year
In Australia, patients and government at odds over mesothelioma treatment costs. Journal of the National Cancer Institute, 2007, Dec-05, Volume: 99, Issue:23 Topics: Abdominal Neoplasms; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Australia; Canada; Carcinogens; Cisplatin; Cost-Benefit Analysis; Environmental Exposure; Glutamates; Government; Guanine; Health Care Costs; Humans; Incidence; Lobbying; Lung Neoplasms; Mesothelioma; Patient Advocacy; Pemetrexed; Quinazolines; Thiophenes; Thoracic Neoplasms; United Kingdom	2007

Article

Year

In Australia, patients and government at odds over mesothelioma treatment costs.

Journal of the National Cancer Institute, 2007, Dec-05, Volume: 99, Issue:23

Topics: Abdominal Neoplasms; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Australia; Canada; Carcinogens; Cisplatin; Cost-Benefit Analysis; Environmental Exposure; Glutamates; Government; Guanine; Health Care Costs; Humans; Incidence; Lobbying; Lung Neoplasms; Mesothelioma; Patient Advocacy; Pemetrexed; Quinazolines; Thiophenes; Thoracic Neoplasms; United Kingdom

2007